Home / Health / AIIMS Delhi Launches Advanced Epilepsy Drug Monitoring
AIIMS Delhi Launches Advanced Epilepsy Drug Monitoring
11 May
Summary
- New therapeutic drug monitoring facility launched for epilepsy patients.
- Aims to improve access to affordable, high-quality neurodiagnostic services.
- Expected to provide relief to underprivileged patients needing specialized tests.
The Neurobiochemistry Laboratory at AIIMS, Delhi, has introduced an advanced Therapeutic Drug Monitoring (TDM) facility, significantly bolstering epilepsy care. This development aims to enhance the quality and affordability of neurodiagnostic services for epilepsy patients across India.
The newly established facility will empower clinicians by enabling accurate monitoring of drug levels. This allows for individualized dose adjustments, better assessment of treatment responses, and early detection of potential drug toxicity. Such capabilities are crucial for optimizing antiepileptic therapy and improving patient outcomes.
AIIMS stated that the availability of these tests within the institution is poised to offer substantial relief. Economically underprivileged patients, who previously incurred significant expenses at private laboratories or external centers, will now have access to these vital investigations at a more affordable rate.
